PT Itama Ranoraya Tbk

IRRA

ID1000151707

Medical Equipment, Supplies & Distribution

End-of-day quote INDONESIA S.E. Other stock markets 23:00:00 27/05/2024 BST			5-day change	1st Jan Change
498 ^IDR	+2.05%		-5.14%	-37.75%

04-02	PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	CI

PT Itama Ranoraya Tbk authorizes a Buyback Plan.

March 11, 2020

The Board of Directors of PT Itama Ranoraya Tbk has authorized a buyback plan on March 12, 2020.

Latest news about PT Itama Ranoraya Tbk

PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2023	04-02	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023	31/10/23	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2023	27/09/23	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023	04/05/23	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2022	29/03/23	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022	29/11/22	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2022	30/08/22	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022	29/05/22	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2021	07/03/22	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021	25/10/21	CI
PT Itama Ranoraya Tbk entered into a conditional share purchase agreement to acquire a 51% stake in PT Oneject Indonesia.	29/09/21	CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2021	05/08/21	CI
PT Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2020	18/02/21	CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Nine Months Ended September 30, 2020	18/10/20	CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Half Year Ended June 30, 2020	30/07/20	CI
PT Itama Ranoraya Tbk's Equity Buyback announced on March 12, 2020, has expired with 113,622,400 shares, representing 7.1% for IDR 59,914.1 million.	30/03/20	CI
Tranche Update on PT Itama Ranoraya Tbk's Equity Buyback Plan announced on March 12, 2020.	30/03/20	CI
PT Itama Ranoraya Tbk announces an Equity Buyback for IDR 60,000 million worth of its shares.	11/03/20	CI
PT Itama Ranoraya Tbk authorizes a Buyback Plan.	11/03/20	CI
Pt Itama Ranoraya Tbk Reports Earnings Results for the Full Year Ended December 31, 2019	03/03/20	CI
PT Itama Ranoraya Tbk has completed an IPO in the amount of IDR 149.6 billion.	10/10/19	CI
PT Itama Ranoraya Tbk has filed an IPO in the amount of IDR 150 billion.	12/09/19	CI

PT Itama Ranoraya Tbk is an Indonesia-based healthcare company engaged in offering healthcare solutions. The Company's main activity is to operate in the field of wholesale trading of laboratory equipment, pharmaceutical equipment, and medical devices for humans. Its segments include In Vitro Diagnostic (IVD) Product, Sterile Non-Electromedical Medical Equipment, Electromedical Medical Equipment, and Others. Its business segment focuses on IVD, medical imaging, surgical, cardiovascular, hospital supplies, critical care, maternal and neonatal care, and pharmaceuticals, among others. In addition to carrying out its main business activities, the Company also leases office space to PT Neumedik Jaya.

Sector

Medical Equipment, Supplies & Distribution

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
PT ITAMA RANORAYA TBK	-37.75%	45.79M
ABBOTT LABORATORIES	-7.38%	181B
MEDTRONIC PLC	-0.46%	108B
BECTON, DICKINSON AND COMPANY	-6.98%	66.12B
DEXCOM, INC.	+2.65%	50.65B
CENCORA, INC.	+5.27%	43.11B
HOYA CORPORATION	+6.33%	40.74B
METTLER-TOLEDO INTERNATIONAL, INC.	+19.92%	31.6B
TERUMO CORPORATION	+16.08%	25.56B
WEST PHARMACEUTICAL SERVICES, INC.	-7.00%	24.16B